2. Patients and Methods
2.1 Patients
Fifty-nine patients with HCC diagnosed in our hospital from July 2016 to June 2019 were enrolled (Table 1). All patients were confirmed as HCC by two or more imaging examinations or liver tumor biopsy, according to the Expert Consensus on Regulation of Standardized Diagnosis and Treatment of Primary Liver Cancer. Twenty-eight patients were followed up regularly after GSMs -TACE treatment for 30 days and the Treg cells proportion in peripheral blood was examined (Fig. 1, Table 2). Ten healthy volunteers were selected as control group.
Table 1 Characteristics of 59 patients with HCC